IGF2 and cancer: Similar observations were made in thyroid cancer and hepatocellular carcinoma (HCC), where undifferentiated cancer cells preferentially expressed higher levels of INSR-A and produced higher levels of IGF-2 in order to activate the autocrine loop (41, 52).